Wegovy approved in China, but Novo Nordisk promises priority to existing patients amid shortages

Topline Ozempic maker Novo Nordisk confirmed Tuesday that its popular weight-loss drug Wegovy had been approved for sale in China, a major win for the Danish company that opens the door to a huge market, but the company told Forbes it will only launch there once it can guarantee supplies for those already using them … Read more

Groundbreaking research reveals a link between obesity, inflammation and aging

SciTechDaily

CNIO researchers have found that cells signaling that they contain excess nutrients can lead to organ malfunction and inflammation, potentially accelerating aging. Using animal models and comparisons with human blood samples, they have shown that targeting inflammation can alleviate the symptoms of aging and extend life, with implications for understanding diseases associated with aging and … Read more